Related Experiment Videos
Cefaclor in the treatment of otitis media with effusion
Insights
Cefaclor treatment significantly improved healing rates in children with chronic otitis media with effusion (OME), reducing the need for surgery. Most treated children healed and avoided operations long-term.
Area of Science:
- Pediatric Otolaryngology
- Clinical Pharmacology
Background:
- Chronic otitis media with effusion (OME) is a common condition in children, often requiring surgical intervention.
- Identifying effective non-surgical treatments for OME is crucial to improve outcomes and reduce healthcare burdens.
Purpose of the Study:
- To evaluate the efficacy of cefaclor in treating chronic otitis media with effusion in children.
- To determine if cefaclor treatment can reduce the need for surgical procedures in pediatric OME cases.
Main Methods:
- A randomized clinical trial involving 91 children diagnosed with chronic OME.
- The treatment group (n=46) received cefaclor 20 mg/kg twice daily for 10 days prior to surgery.
- The control group (n=45) received no treatment before the scheduled surgery.
Main Results:
- On the day of surgery, 52% of the cefaclor-treated children showed healed OME, compared to 11% in the untreated group (p<0.001).
- Long-term follow-up (median 20 months) showed 18 of the 24 initially healed treated children remained unoperated.
- Two children in the untreated group relapsed and required surgery.
Conclusions:
- Cefaclor demonstrates significant efficacy in promoting the resolution of chronic otitis media with effusion in children.
- Pre-surgical administration of cefaclor can substantially decrease the number of children requiring surgery for OME and offers sustained benefits.
Abstract:
A randomized clinical trial in which 91 children with chronic OME participated was performed. Cefaclor 20 mg/kg body weight b.i.d. was given to the treated group (n = 46) during 10 days preceding the day appointed for surgery. The control group (n = 45) remained untreated. On the day scheduled for surgery 24 (52%) of the treated cases had healed, compared to 5 (11%) of the untreated cases, a significant difference (p less than 0.001). The long term effects showed that in the treated group 18 of the 24 primarily healed remained unoperated at a median follow-up period of 20 months. In the untreated group two of the five that originally resolved later relapsed and were subjected to surgery.